Search

everythinglearnresearchcommunity

for

Search:↓

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Women with acne have lower levels of a specific hormone marker than women without acne.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Lifestyle changes and medication can improve the quality of life for women with PCOS by reducing complications.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Finasteride may help some women with hair loss, but better options exist.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Higher serum ferritin levels than currently used might be needed to rule out iron deficiency in women with hair loss.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.